Peter Lurie, a former FDA official who now directs the Center for Science in the Public Interest, described allowing peptides to market without clinical testing as a "profound threat" to the FDA's decades-long drug vetting system
Glucose transporters such as GLUT1, GLUT3, GLUT4, GLUT8, SGLT1 and SGLT6 have been found to be expressed in various brain regions [60]
They're all downstream of the same underlying cellular environment
Superoxide dismutase catalyzes the dismutation reaction of superoxide to hydrogen peroxide, which is further catalyzed to the highly reactive hydroxyl radical and ultimately to water by glutathione peroxidase and catalase enzymes
The drug isnt even named at checkout, listed only as GLP-1, so patients are asked to pay before knowing exactly what theyre paying for